Melkonian Capital Management

Melkonian Capital Management is a New York-based investment management firm and hedge fund manager focused on private equity, real estate, and public market investments. The firm uses a value-oriented, bottom-up, research-driven approach to build a concentrated portfolio of high-conviction holdings. It appears to manage pooled investment vehicles and has been associated with healthcare-related holdings such as Sebela and Eyevance, but it is not itself a biotech, pharma, or healthcare operating company. For life sciences analysts, the company is better understood as a financial sponsor or investor with exposure to healthcare assets rather than a drug developer, platform biotech, CRO, or CDMO.